Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00728936
Brief Title: Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients

First Submitted : August 1, 2008
First Submitted that Met QC Criteria : August 5, 2008
First Posted : August 6, 2008 (Estimate)

Results First Submitted : November 28, 2017
Results First Submitted that Met QC Criteria : September 28, 2018
Results First Posted : February 15, 2019

Last Update Submitted that Met QC Criteria : September 28, 2018
Last Update Posted : February 15, 2019